Browsing Category
Pharma Industry News
4754 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
New drug launch sends Lupin shares soaring to record highs! Find out what’s next
Lupin Limited, a global pharmaceutical major, has seen its share price reach a 52-week high following the launch…
Athira Pharma stock nosedives after Alzheimer’s drug trial results disappoint
Athira Pharma’s stock plunged by 75% after the company announced that its Phase 2/3 LIFT-AD clinical trial for…
Biopharma shake-up: Semnur Pharmaceuticals to merge with Denali Capital in $2.5bn deal
In a significant development within the biopharmaceutical industry, Semnur Pharmaceuticals, Inc. (“Semnur”), a wholly owned subsidiary of Scilex…
Fresenius sells IV manufacturing site in Chile to Medifarma as part of streamlining efforts
Fresenius SE & Co. KGaA, a global healthcare company headquartered in Germany, announced the divestment of its intravenous…
Emergent BioSolutions’ ACAM2000 receives FDA approval for Mpox prevention
Emergent BioSolutions Inc. (NYSE: EBS) has achieved a notable milestone with the U.S. Food and Drug Administration (FDA)…
Novavax’s 2024-2025 COVID-19 Vaccine Receives EUA for Use in the U.S.
Novavax, Inc. (Nasdaq: NVAX), a leading company in protein-based vaccines, has announced that its latest COVID-19 vaccine, the…
Vutrisiran : Alnylam Pharmaceuticals reveals positive results from HELIOS-B Phase 3 study
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a pioneer in RNA interference (RNAi) therapeutics, has unveiled promising results from the…
Huge pharmaceutical deal: Platinum Equity gains control of Inventia Healthcare’s key division
In a significant move within the global pharmaceutical sector, Platinum Equity has secured a controlling stake in the…
UTime to acquire Bowen Therapeutics to enhance monkeypox vaccine development
UTime Limited (NASDAQ: WTO), a prominent player in the healthcare sector, has officially signed a non-disclosure agreement (NDA)…
EC approves PADCEV and KEYTRUDA combo for advanced urothelial cancer treatment
Astellas Pharma Inc. has announced a significant milestone in cancer treatment with the European Commission (EC’s) approval of…